US And EU Pricing Pressures Will Squeeze Biologics Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
16 Jun 25
Updated
23 Jul 25
AnalystLowTarget's Fair Value
DKK 1,000.00
43.1% overvalued intrinsic discount23 Jul
DKK 1,431.00
1Y
-20.4%7D
-2.5%